Guilin Sanjin Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -9.98% vs 25.71% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 159.71% vs -51.32% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "525.10",
          "val2": "583.30",
          "chgp": "-9.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "142.10",
          "val2": "99.40",
          "chgp": "42.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "16.70",
          "chgp": "-94.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.70",
          "val2": "2.40",
          "chgp": "-29.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "124.40",
          "val2": "47.90",
          "chgp": "159.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "270.70%",
          "val2": "123.60%",
          "chgp": "14.71%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -6.74% vs 1.10% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -16.95% vs 23.78% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,025.00",
          "val2": "2,171.40",
          "chgp": "-6.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "616.00",
          "val2": "606.70",
          "chgp": "1.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "20.10",
          "val2": "14.10",
          "chgp": "42.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.70",
          "val2": "4.70",
          "chgp": "63.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "433.10",
          "val2": "521.50",
          "chgp": "-16.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "250.90%",
          "val2": "221.20%",
          "chgp": "2.97%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

525.10

583.30

-9.98%

Operating Profit (PBDIT) excl Other Income

142.10

99.40

42.96%

Interest

1.00

16.70

-94.01%

Exceptional Items

1.70

2.40

-29.17%

Consolidate Net Profit

124.40

47.90

159.71%

Operating Profit Margin (Excl OI)

270.70%

123.60%

14.71%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -9.98% vs 25.71% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 159.71% vs -51.32% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

2,025.00

2,171.40

-6.74%

Operating Profit (PBDIT) excl Other Income

616.00

606.70

1.53%

Interest

20.10

14.10

42.55%

Exceptional Items

7.70

4.70

63.83%

Consolidate Net Profit

433.10

521.50

-16.95%

Operating Profit Margin (Excl OI)

250.90%

221.20%

2.97%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -6.74% vs 1.10% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -16.95% vs 23.78% in Dec 2024

All Annual Results